XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Operating Activities:          
Net loss $ (269,172) $ (3,239,229) $ (353,830) $ (24,041,605) $ (25,006,486)
Amortization of debt discount     17,768 14,290  
Interest and amortization of discount on convertible notes     523,481  
(Profit) Loss from marketable securities     2,365 (8,323)  
Shares and warrants issued for services     79,335 1,044,144  
Finance loss arising from change in terms of convertible notes     (145,932) 21,472,897  
Decrease in net liabilities for sale     (53,383)  
Increase in accounts payable and accrued expenses     85,669 51,084  
Increase in deferred revenues     50,000  
Increase in accrued interest     10,556  
Decrease in other receivables     22,572 12,222  
Net cash used operating activities     (281,497) (935,193)  
Investing Activities:          
Selling of marketable securities     14,877  
Net cash provided by investing activities     14,877  
Financing Activities:          
Proceeds from sale of common stock and warrants (net of issuance expenses)     1,940,950  
Exercise of options     63  
Issuance of convertible note     100,000  
Net cash provided by financing activities     2,041,013  
Net increase in cash     (266,620) 1,105,820  
Cash and cash equivalents - beginning of period     499,919 2,959 2,959
Cash and cash equivalents - end of period $ 233,299 $ 1,108,779 233,299 1,108,779 $ 499,919
Non-cash transactions:          
Increase in deferred revenues against short-term investment     50,000  
Issuance of shares in respect of proceeds received during 2017     (80,000)  
Common stock issued pursuant to convertible note     $ 85,218